Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS approval · 2026-02-18

Clinical Trial Update: Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of the Thoracoabdominal and Pararenal Aortic Aneurysms (TAMBE)

View source ↗

Summary

The TAMBE trial evaluating the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis has been approved for marketing for the treatment of thoracoabdominal aneury…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Thoracoabdominal Aneurysm | Status: APPROVED_FOR_MARKETING